Etravirine Tablet
Product Images NDC 69315-285

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Etravirine (NDC 69315-285). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Leading Pharma, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemicalstructure (Chemicalstructure)

Chemical structure diagram of the active ingredient Etravirine, showing its molecular arrangement with nitrogen, oxygen, bromine atoms, and aromatic rings as typically depicted in pharmaceutical labeling.*

FDA Label Image

Containerlabel100mg (Containerlabel100mg)

Label for Etravirine Tablets 100 mg oral tablets. The label states each tablet contains 100 mg of etravirine and includes storage instructions at 25°C (77°F) with permitted excursions. It notes the product is manufactured by Carnegie Pharmaceuticals LLC and distributed by Leading Pharma, LLC. The package contains 120 tablets and is marked Rx only.*

FDA Label Image

Containerlabel200mg (Containerlabel200mg)

Etravirine Tablets 200 mg oral tablets label for a 60-tablet bottle. The label includes dosage information, manufacturer Carnegie Pharmaceuticals LLC, and distributor Leading Pharma, LLC. It features warnings and storage instructions, with the Leading Pharma logo at the bottom.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.